Biofrontera AG (BFRA) stock is down -41.07% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BFRA stock a score of 28 out of a possible 100. That rank is primarily influenced by a short-term technical score of 2. BFRA's rank also includes a long-term technical score of 3. The fundamental score for BFRA is 79. In addition to the average rating from Wall Street analysts, BFRA stock has a mean target price of $8.00. This means analysts expect the stock to rise 90.93% over the next 12 months.
News Home
Biofrontera AG (BFRA) Stock Has Fallen -6.68% This Week: Buy, Hold, or Sell?
Mentioned in this article
BFRA has an Overall Score of 28. Find out what this means to you and get the rest of the rankings on BFRA!